Evaluation of 'opt-in' approach to cervical-length screening for reducing preterm birth
- PMID: 34254380
- DOI: 10.1002/uog.23736
Evaluation of 'opt-in' approach to cervical-length screening for reducing preterm birth
References
-
- Fonseca EB, Celik E, Parra M, Singh M, Nicolaides KH; Fetal Medicine Foundation Second Trimester Screening Group. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med 2007; 357: 462-469.
-
- Hassan SS, Romero R, Vidyadhari D, Fusey S, Baxter JK, Khandelwal M, Vijayaraghavan J, Trivedi Y, Soma-Pillay P, Sambarey P, Dayal A, Potapov V, O'Brien J, Astakhov V, Yuzko O, Kinzler W, Dattel B, Sehdev H, Mazheika L, Manchulenko D, Gervasi MT, Sullivan L, Conde-Agudelo A, Phillips JA, Creasy GW; PREGNANT Trial. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2011; 38: 18-31.
-
- Temming LA, Durst JK, Tuuli MG, Stout MJ, Dicke JM, Macones GA, Cahill AG. Universal cervical length screening: implementation and outcomes. Am J Obstet Gynecol 2016; 214: 523.e1-8.
-
- Orzechowski KM, Boelig RC, Baxter JK, Berghella V. A universal transvaginal cervical length screening program for preterm birth prevention. Obstet Gynecol 2014; 124: 520-525.
-
- Son M, Grobman WA, Ayala NK, Miller ES. A universal mid-trimester transvaginal cervical length screening program and its associated reduced preterm birth rate. Am J Obstet Gynecol 2016; 214: 365.e1-5.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
